# Nemtabrutinib and Lisocabtagene Maraleucel for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

> clinical trial · VERIFIED · 2026-08-12

Status: RECRUITING · Sponsor: Fred Hutchinson Cancer Center · Condition: Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

- Company: Fred Hutchinson Cancer Center
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07194980

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.